8.365USD+1.39%Mkt Cap: 49.87M USDP/E: —Last update: 2026-05-26
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap49.87M USD
Enterprise Value-92.39M USD
Revenue (TTM)53.48M USD
Gross Profit53.48M USD
Net Income (TTM)-35.04M USD
Revenue/Share9.249 USD
Last Price8.365 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-14.78
PEG—
EV/EBITDA2.26
EV/Revenue-1.73
P/S0.96
P/B1.10
EPS (TTM)-2.28
EPS (Forward)-0.58
52W Range
6.46820% of range16.10
52W High16.10 USD
52W Low6.468 USD
Profitability
Gross Margin100.00%
Oper. Margin-111.58%
EBITDA Margin-76.39%
Profit Margin-80.05%
ROE-99.33%
ROA-22.65%
Growth
Revenue Growth331.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.99M USD
CapEx (TTM)518.00K USD
FCF Margin-44.33%
FCF Yield-47.54%
Net Debt-143.69M USD
Net Debt/EBITDA3.52
Balance Sheet
Debt/Equity0.20
Current Ratio3.59
Quick Ratio3.50
Book Value/Sh7.785 USD
Cash/Share25.13 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:14
Split DateMar 16, 2026
Analyst Consensus
Rating—
Target (Mean)20.00 USD
Target Range20.00 USD – 20.00 USD
# Analysts1
Ownership
Shares Out.5.98M
Float3.65M
Insiders28.49%
Institutions38.03%
Short Interest
Short Ratio5.0d
Short % Float3.08%
Short % Out.2.72%
Shares Short162.96K
Short (prev mo.)182.49K
Technical
SMA 508.166 (+2.4%)
SMA 2009.327 (-10.3%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)55.70K
Avg Vol (10d)97.02K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—